85 related articles for article (PubMed ID: 12112320)
21. Estrogen receptor activation at serine 305 is sufficient to upregulate cyclin D1 in breast cancer cells.
Balasenthil S; Barnes CJ; Rayala SK; Kumar R
FEBS Lett; 2004 Jun; 567(2-3):243-7. PubMed ID: 15178330
[TBL] [Abstract][Full Text] [Related]
22. Thyroid hormone receptor-beta (TR beta 1) impairs cell proliferation by the transcriptional inhibition of cyclins D1, E and A2.
Porlan E; Vidaurre OG; Rodríguez-Peña A
Oncogene; 2008 Apr; 27(19):2795-800. PubMed ID: 18037966
[TBL] [Abstract][Full Text] [Related]
23. Synergistic effect of cyclin D1 and c-Myc leads to more aggressive and invasive mammary tumors in severe combined immunodeficient mice.
Wang Y; Thakur A; Sun Y; Wu J; Biliran H; Bollig A; Liao DJ
Cancer Res; 2007 Apr; 67(8):3698-707. PubMed ID: 17440082
[TBL] [Abstract][Full Text] [Related]
24. Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1.
Chen C; Chang YC; Liu CL; Chang KJ; Guo IC
Breast Cancer Res Treat; 2006 Jul; 98(2):121-32. PubMed ID: 16752079
[TBL] [Abstract][Full Text] [Related]
25. Estrogen receptors alfa (ERalpha) and beta (ERbeta) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11.
Helguero LA; Faulds MH; Gustafsson JA; Haldosén LA
Oncogene; 2005 Oct; 24(44):6605-16. PubMed ID: 16007178
[TBL] [Abstract][Full Text] [Related]
26. Heregulin beta1 promotes breast cancer cell proliferation through Rac/ERK-dependent induction of cyclin D1 and p21Cip1.
Yang C; Klein EA; Assoian RK; Kazanietz MG
Biochem J; 2008 Feb; 410(1):167-75. PubMed ID: 17941827
[TBL] [Abstract][Full Text] [Related]
27. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.
Suzui M; Masuda M; Lim JT; Albanese C; Pestell RG; Weinstein IB
Cancer Res; 2002 Jul; 62(14):3997-4006. PubMed ID: 12124333
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of cell-cycle effectors of proliferation in bladder tumor epithelial cells by the p75NTR tumor suppressor.
Khwaja F; Djakiew D
Mol Carcinog; 2003 Mar; 36(3):153-60. PubMed ID: 12619038
[TBL] [Abstract][Full Text] [Related]
29. IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells.
Fleming JM; Leibowitz BJ; Kerr DE; Cohick WS
J Endocrinol; 2005 Jul; 186(1):165-78. PubMed ID: 16002546
[TBL] [Abstract][Full Text] [Related]
30. Cyclin D1 induction of cellular migration requires p27(KIP1).
Li Z; Jiao X; Wang C; Ju X; Lu Y; Yuan L; Lisanti MP; Katiyar S; Pestell RG
Cancer Res; 2006 Oct; 66(20):9986-94. PubMed ID: 17047061
[TBL] [Abstract][Full Text] [Related]
31. Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression.
Corsino P; Davis B; Law M; Chytil A; Forrester E; Nørgaard P; Teoh N; Law B
Cancer Res; 2007 Apr; 67(7):3135-44. PubMed ID: 17409420
[TBL] [Abstract][Full Text] [Related]
32. Dienogest, a synthetic progestin, inhibits the proliferation of immortalized human endometrial epithelial cells with suppression of cyclin D1 gene expression.
Shimizu Y; Takeuchi T; Mita S; Mizuguchi K; Kiyono T; Inoue M; Kyo S
Mol Hum Reprod; 2009 Oct; 15(10):693-701. PubMed ID: 19502247
[TBL] [Abstract][Full Text] [Related]
33. Regulation of smooth muscle cell proliferation by beta-catenin/T-cell factor signaling involves modulation of cyclin D1 and p21 expression.
Quasnichka H; Slater SC; Beeching CA; Boehm M; Sala-Newby GB; George SJ
Circ Res; 2006 Dec; 99(12):1329-37. PubMed ID: 17122440
[TBL] [Abstract][Full Text] [Related]
34. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E
BMC Cancer; 2006 Mar; 6():58. PubMed ID: 16536875
[TBL] [Abstract][Full Text] [Related]
35. Steroid hormone receptor expression and proliferation in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Qiu C; Shan L; Yu M; Snyderwine EG
Carcinogenesis; 2005 Apr; 26(4):763-9. PubMed ID: 15637090
[TBL] [Abstract][Full Text] [Related]
36. v-erbA stimulates quail myoblast differentiation in a T3 independent, cell-specific manner.
Cassar-Malek I; Marchal S; Altabef M; Wrutniak C; Samarut J; Cabello G
Oncogene; 1994 Aug; 9(8):2197-206. PubMed ID: 7913543
[TBL] [Abstract][Full Text] [Related]
37. Progesterone, in addition to estrogen, induces cyclin D1 expression in the murine mammary epithelial cell, in vivo.
Said TK; Conneely OM; Medina D; O'Malley BW; Lydon JP
Endocrinology; 1997 Sep; 138(9):3933-9. PubMed ID: 9275084
[TBL] [Abstract][Full Text] [Related]
38. v-erbA oncogene induces invasiveness and anchorage-independent growth in cultured glial cells by mechanisms involving platelet-derived growth factor.
Llanos S; Iglesias T; Riese HH; Garrido T; Caelles C; Muñoz A
Cell Growth Differ; 1996 Mar; 7(3):373-82. PubMed ID: 8838867
[TBL] [Abstract][Full Text] [Related]
39. The v-ErbA oncoprotein quenches the activity of an erythroid-specific enhancer.
Braliou GG; Ciana P; Klaassen W; Gandrillon O; Stunnenberg HG
Oncogene; 2001 Feb; 20(7):775-87. PubMed ID: 11314012
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory function of whey acidic protein in the cell-cycle progression of mouse mammary epithelial cells (EpH4/K6 cells).
Ikeda K; Nukumi N; Iwamori T; Osawa M; Naito K; Tojo H
J Reprod Dev; 2004 Feb; 50(1):87-96. PubMed ID: 15007206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
